These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7619665)

  • 1. The opiate addiction test: a clinical evaluation of a quick test for physical dependence on opiate drugs.
    Ghodse H; Taylor DR; Greaves JL; Britten AJ; Lynch D
    Br J Clin Pharmacol; 1995 Mar; 39(3):257-9. PubMed ID: 7619665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naloxone applied to conjunctiva as a test for physical opiate dependence.
    Creighton FJ; Ghodse AH
    Lancet; 1989 Apr; 1(8641):748-50. PubMed ID: 2564564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pupillometric changes during gradual opiate detoxification correlate with changes in symptoms of opiate withdrawal as measured by the Weak Opiate Withdrawal Scale.
    Rosse RB; Johri S; Goel M; Rahman F; Jawor KA; Deutsch SI
    Clin Neuropharmacol; 1998; 21(5):312-5. PubMed ID: 9789712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular absorption of naloxone in narcotic addicts.
    Duncalf D; Jeyaram C; Tarter R; Foldes FF
    Int J Addict; 1975; 10(1):23-7. PubMed ID: 1126766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the opioid addiction test in an out-patient drug dependency unit.
    Ghodse AH; Greaves JL; Lynch D
    Br J Psychiatry; 1999 Aug; 175():158-62. PubMed ID: 10627799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mydriatic response to topical naloxone in opiate abusers.
    Ghodse AH; Bewley TH; Kearney MK; Smith SE
    Br J Psychiatry; 1986 Jan; 148():44-6. PubMed ID: 3955319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buprenorphine and naloxone interactions in methadone maintenance patients.
    Mendelson J; Jones RT; Welm S; Brown J; Batki SL
    Biol Psychiatry; 1997 Jun; 41(11):1095-101. PubMed ID: 9146820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rating the presence and severity of opiate dependence.
    Wang RI; Wiesen RL; Lamid S; Roh BL
    Clin Pharmacol Ther; 1974 Oct; 16(4):653-8. PubMed ID: 4422361
    [No Abstract]   [Full Text] [Related]  

  • 9. Naloxone eye drops reverse the miosis in runners--implications for an endogenous opiate test.
    Allen M; Thierman J; Hamilton D
    Can J Appl Sport Sci; 1983 Jun; 8(2):98-103. PubMed ID: 6883621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pupillary response to methadone challenge in heroin users.
    Higgins ST; Stitzer ML; McCaul ME; Bigelow GE; Liebson IA
    Clin Pharmacol Ther; 1985 Apr; 37(4):460-3. PubMed ID: 3979006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consensual pupillary responses to mydriatic and miotic drugs.
    Theofilopoulos N; Longmore J; Kerr FA; Szabadi E; Bradshaw CM
    Br J Clin Pharmacol; 1988 Dec; 26(6):697-702. PubMed ID: 3242574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of digital pupillometry for diagnosis of Horner syndrome.
    Yoo YJ; Yang HK; Hwang JM
    PLoS One; 2017; 12(6):e0178361. PubMed ID: 28575101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medically assisted recovery from opiate dependence within the context of the UK drug strategy: methadone and Suboxone (buprenorphine-naloxone) patients compared.
    McKeganey N; Russell C; Cockayne L
    J Subst Abuse Treat; 2013 Jan; 44(1):97-102. PubMed ID: 22703715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of narcotic use. Comparison of the nalorphine (pupil) test with chemical tests.
    Elliott HW; Nomof N; Parker KD; Turgeon GR
    Calif Med; 1968 Aug; 109(2):121-5. PubMed ID: 5673987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pupil dilation using drops vs gel: a comparative study.
    Moisseiev E; Loberman D; Zunz E; Kesler A; Loewenstein A; Mandelblum J
    Eye (Lond); 2015 Jun; 29(6):815-9. PubMed ID: 25857606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical studies with naloxone/methadone in a ratio of 1:20.
    Bloom WA; Sudderth EW; Marcello L
    Proc Natl Conf Methadone Treat; 1973; 2():1342-9. PubMed ID: 4612372
    [No Abstract]   [Full Text] [Related]  

  • 17. Methadone and naloxone in combination (Naldone) for the treatment of heroin addicts.
    Caruso FS; Gordon M; Pachter IJ
    Proc Natl Conf Methadone Treat; 1973; 2():1336-41. PubMed ID: 4215978
    [No Abstract]   [Full Text] [Related]  

  • 18. Naloxone induces miosis in normal subjects.
    Loimer N; Schmid R; Grünberger J; Linzmayer L
    Psychopharmacology (Berl); 1990; 101(2):282-3. PubMed ID: 2349371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphine-induced mydriasis and inhibition of pupillary light reflex and fluctuations in the cat.
    Pickworth WB; Sharpe LG
    J Pharmacol Exp Ther; 1985 Sep; 234(3):603-6. PubMed ID: 2993586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mydriatic effect of ocular decongestants studied by pupillography.
    Gelmi C; Ceccuzzi R
    Ophthalmologica; 1994; 208(5):243-6. PubMed ID: 7816414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.